Functional Consequences of Pathogenic Variants of the GJB2 Gene (Cx26) Localized in Different Cx26 Domains

Biomolecules. 2023 Oct 13;13(10):1521. doi: 10.3390/biom13101521.

Abstract

One of the most common forms of genetic deafness has been predominantly associated with pathogenic variants in the GJB2 gene, encoding transmembrane protein connexin 26 (Cx26). The Cx26 molecule consists of an N-terminal domain (NT), four transmembrane domains (TM1-TM4), two extracellular loops (EL1 and EL2), a cytoplasmic loop, and a C-terminus (CT). Pathogenic variants in the GJB2 gene, resulting in amino acid substitutions scattered across the Cx26 domains, lead to a variety of clinical outcomes, including the most common non-syndromic autosomal recessive deafness (DFNB1A), autosomal dominant deafness (DFNA3A), as well as syndromic forms combining hearing loss and skin disorders. However, for rare and poorly documented variants, information on the mode of inheritance is often lacking. Numerous in vitro studies have been conducted to elucidate the functional consequences of pathogenic GJB2 variants leading to amino acid substitutions in different domains of Cx26 protein. In this work, we summarized all available data on a mode of inheritance of pathogenic GJB2 variants leading to amino acid substitutions and reviewed published information on their functional effects, with an emphasis on their localization in certain Cx26 domains.

Keywords: Cx26 domains; GJB2; hereditary hearing loss; non-synonymous variants.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Connexin 26* / genetics
  • Connexins / genetics
  • Deafness / genetics
  • Hearing Loss* / genetics
  • Hearing Loss, Sensorineural / genetics
  • Humans
  • Mutation

Substances

  • Connexin 26
  • Connexins
  • GJB2 protein, human

Grants and funding

This work was supported by the Ministry of Education and Science of the Russian Federation (Grant No. FSUS-2020-0040 to O.L.P., E.A.M., V.Y.D. and K.E.O.) and by the projects of the Institute of Cytology and Genetics SB RAS (Grant No. FWNR-2022-0003 to V.Y.D. and M.V.Z., and Grant No. FWNR-2022-0021 to O.L.P.).